Literature DB >> 16798987

A constrained acetabular component for recurrent dislocation.

R J K Khan1, D Fick, R Alakeson, S Haebich, M de Cruz, B Nivbrant, D Wood.   

Abstract

We treated 34 patients with recurrent dislocation of the hip with a constrained acetabular component. Roentgen stereophotogrammetric analysis was performed to assess migration of the prosthesis. The mean clinical follow-up was 3.0 years (2.2 to 4.8) and the radiological follow-up was 2.7 years (2.0 to 4.8). At the latest review six patients had died and none was lost to follow-up. There were four acetabular revisions, three for aseptic loosening and one for deep infection. Another acetabular component was radiologically loose with progressive radiolucent lines in all Gruen zones and was awaiting revision. The overall rate of aseptic loosening was 11.8% (4 of 34). Roentgen stereophotogrammetric analysis in the non-revised components confirmed migration of up to 1.06 mm of translation and 2.32 degrees of rotation at 24 months. There was one case of dislocation and dissociation of the component in the same patient. Of the 34 patients, 33 (97.1%) had no further episodes of dislocation. The constrained acetabular component reported in our study was effective in all but one patient with instability of the hip, but the rate of aseptic loosening was higher than has been reported previously and requires further investigation.

Entities:  

Mesh:

Year:  2006        PMID: 16798987     DOI: 10.1302/0301-620X.88B7.17644

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  18 in total

1.  The use of a cemented dual mobility socket to treat recurrent dislocation.

Authors:  Moussa Hamadouche; David J Biau; Denis Huten; Thierry Musset; François Gaucher
Journal:  Clin Orthop Relat Res       Date:  2010-12       Impact factor: 4.176

2.  All dual mobility cups are not the same.

Authors:  Thierry Aslanian
Journal:  Int Orthop       Date:  2017-01-18       Impact factor: 3.075

Review 3.  The evolution of outcomes and indications for the dual-mobility cup: a systematic review.

Authors:  Cécile Batailler; Camdon Fary; Régis Verdier; Thierry Aslanian; Jacques Caton; Sebastien Lustig
Journal:  Int Orthop       Date:  2016-12-21       Impact factor: 3.075

4.  A dual-mobility cup reduces risk of dislocation in isolated acetabular revisions.

Authors:  Roberto Civinini; Christian Carulli; Fabrizio Matassi; Lorenzo Nistri; Massimo Innocenti
Journal:  Clin Orthop Relat Res       Date:  2012-06-15       Impact factor: 4.176

5.  Relevance of a press-fit dual mobility cup to deal with recurrent dislocation of conventional total hip arthroplasty: a 29-case series.

Authors:  D Saragaglia; S Ruatti; R Refaie
Journal:  Eur J Orthop Surg Traumatol       Date:  2012-05-06

6.  Constrained liner in neurologic or cognitively impaired patients undergoing primary THA.

Authors:  Philippe Hernigou; Paolo Filippini; Charles-Henri Flouzat-Lachaniette; Sobrinho Uirassu Batista; Alexandre Poignard
Journal:  Clin Orthop Relat Res       Date:  2010-12       Impact factor: 4.176

7.  Total hip arthroplasty in Parkinson's disease - A systematic review of the current evidence.

Authors:  Daniel McCormack; Khalis Boksh; Nomaan Sheikh
Journal:  J Orthop       Date:  2021-03-31

8.  Recurrence of dislocation following total hip arthroplasty revision using dual mobility cups was rare in 180 hips followed over 7 years.

Authors:  Patrice Mertl; Antoine Combes; Frédérique Leiber-Wackenheim; Michel Henri Fessy; Julien Girard; Henri Migaud
Journal:  HSS J       Date:  2012-09-19

9.  Successful closed reduction of a dislocated constrained total hip arthroplasty: a case report and literature review.

Authors:  Motoki Sonohata; Warit Waewsawangwong; Stuart B Goodman
Journal:  Open Orthop J       Date:  2012-05-30

10.  Outcome and risk factors of failures associated with revision total hip arthroplasty for recurrent dislocation.

Authors:  Christian Klemt; Wenhao Chen; Georges Bounajem; Venkatsaiakhil Tirumala; Liang Xiong; Young-Min Kwon
Journal:  Arch Orthop Trauma Surg       Date:  2021-02-18       Impact factor: 2.928

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.